Free, source-traceable HIV knowledge

History

Combination therapy

The scientific, medical, social and community history of the global HIV response.

Publisher
The Bach Foundation
Audience
Public · Professional · Research
Last reviewed
18 August 2026
Status
Source-linked
Jurisdiction
Global context; local guidance may vary

Essential answer

Combination therapy is part of the Center’s history record.

HIV history connects scientific discovery, community activism, clinical research, rights and global programme delivery. Dates and achievements should be attributed without erasing people harmed or excluded along the way.

Complete public explanation

The scientific, medical, social and community history of the global HIV response.

Use the information with its source date, population and jurisdiction. A general explanation cannot determine an individual’s diagnosis, eligibility, regimen or legal obligations.

Key considerations

  • Distinguish the history of the virus from the history of recognized cases and the response.
  • Community activism changed trial design, access and public accountability.
  • Combination antiretroviral therapy transformed survival but did not end unequal access.
  • Prevention, U=U and PrEP milestones depend on cumulative evidence rather than one announcement.

Research and evidence questions

01Which communities and regions remain underrepresented in the historical record?
02How did policy and activism change research practice?
03Which past access failures are repeating with new technologies?
04How should disputed or changing historical claims be documented?

Professional and academic evidence

Professional interpretation of combination therapy adds study design, population, comparator, outcomes, statistical methods, limitations, conflicts, guideline adoption, geographic applicability, replication and integrity status.

Evidence record fields for Combination therapy
FieldWhat the Center displays
Meaning and scopeDefinition, mechanism, intended use and what should not be inferred.
Population and jurisdictionAge, sex and gender, geography, HIV subtype, clinical context and issuing authority.
OutcomeClinical, virologic, diagnostic, public-health or implementation outcome and follow-up.
ProvenanceOriginal source, identifier, version, funding, conflicts, access date and review.
IntegrityProtocol changes, corrections, expressions of concern, retractions and later evidence.
Additional permanent evidence gateways